Welcome to Paid Research Studies




  • Conditions:   Congenital Adrenal Hyperplasia;   Hyperplasia;   Adrenal Hyperplasia;   Congenital Disorders;   Adrenocortical Hyperfunction;   Disorders of Sex Development;   Urogenital Abnormalities;   Genetic Diseases, Inborn;   Steroid Metabolic Diseases, Inborn;   Adrenal Gland Disease;   Hydrocortisone
    Interventions:   Drug: Subcutaneous hydrocortisone;   Drug: Standard glucocorticoid therapy
    Sponsor:   University of Minnesota - Clinical and Translational Science Institute
    Recruiting

  • Conditions:   Pain;   Arthrofibrosis;   Osteoarthritis, Knee
    Interventions:   Drug: Hydrocortisone;   Drug: Saline
    Sponsor:   Hospital for Special Surgery, New York
    Not yet recruiting

  • Condition:   Depression
    Interventions:   Drug: Hydrocortisone acetate;   Drug: Placebo
    Sponsor:   Stanford University
    Recruiting

  • Condition:   Septic Shock
    Interventions:   Drug: Combination (Hydrocortisone and Fludrocortisone);   Drug: Hydrocortisone
    Sponsor:   University of Tennessee Medical Center
    Recruiting

  • Condition:   Internal Hemorrhoids
    Interventions:   Drug: Hydrocortisone Acetate Suppository, 25 mg;   Drug: Placebo (Vehicle) Suppository
    Sponsor:   Nivagen Pharmaceuticals Inc.
    Recruiting

  • Condition:   Hiv
    Interventions:   Drug: Hydrocortisone;   Drug: Placebo Oral Tablet
    Sponsors:   Johns Hopkins University;   National Institute of Mental Health (NIMH)
    Recruiting

  • Conditions:   Hydrocortisone;   Depression;   Healthy Volunteers
    Interventions:   Drug: Hydrocortisone Oral;   Drug: Placebo Oral Tablet
    Sponsors:   University of Texas Southwestern Medical Center;   University of California, Irvine
    Not yet recruiting

  • Condition:   Chronic Rhinosinusitis (Diagnosis)
    Intervention:   Drug: Nasal Mometasone Rinse
    Sponsors:   Rush University Medical Center;   Advanced Rx
    Recruiting

  • Condition:   Parkinson Disease
    Intervention:   Other: No Intervention - Observational Study
    Sponsors:   Oregon Health and Science University;   Portland VA Medical Center;   Oregon Clinical and Translational Research Institute
    Recruiting

  • Conditions:   Colorectal Cancer;   Head and Neck Cancer
    Interventions:   Drug: Doxycycline;   Drug: Hydrocortisone 1% cream;   Other: Sunscreen;   Other: Moisturizer;   Drug: Clindamycin;   Drug: Medrol-dose pack (Steroid)
    Sponsors:   University of Louisville;   James Graham Brown Cancer Center
    Recruiting

  • Conditions:   Hypoxic-Ischemic Encephalopathy;   Neonatal Encephalopathy
    Interventions:   Behavioral: Holding;   Other: Saliva collection;   Behavioral: No Holding
    Sponsor:   Maine Medical Center
    Recruiting

  • Condition:   Sleep Restriction
    Interventions:   Drug: Ketoconazole Pill (also known as nizoral);   Drug: Ganirelix;   Drug: Dexamethasone Pill;   Drug: Dexamethasone injection;   Drug: Cosyntropin Injectable Product;   Drug: Recombinant Human Luteinizing Hormone (also known as luveris);   Drug: Hydrocortisone Injection (also known as solu-cortef);   Drug: Gonadorelin (also known as Lutrepulse);   Drug: Corticorelin (also known as Acthrel);   Drug: Placebo oral tablet;   Drug: Saline Solution;   Drug: Saline solution for injection
    Sponsor:   Los Angeles Biomedical Research Institute
    Recruiting

  • Conditions:   Delirium;   Confusion
    Interventions:   Behavioral: Confusion Assessment Method;   Device: Accelerometer;   Device: Commercially available camera;   Device: Internet Pod (iPod);   Diagnostic Test: Cortisol Swab
    Sponsors:   University of Florida;   U.S. National Science Foundation;   National Institute for Biomedical Imaging and Bioengineering (NIBIB)
    Recruiting

  • Condition:   Acute Lymphoblastic Leukemia
    Interventions:   Drug: Inotuzumab ozogamicin;   Drug: Methotrexate;   Drug: Hydrocortisone;   Drug: Cytarabine;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Drug: Methylprednisolone
    Sponsors:   St. Jude Children's Research Hospital;   Pfizer
    Recruiting

  • Conditions:   Atopic Dermatitis;   Eczema
    Interventions:   Drug: Crisaborole;   Drug: Hydrocortisone Ointment;   Drug: Triamcinolone ointment;   Drug: Aquaphor
    Sponsors:   Johns Hopkins University;   Pfizer
    Recruiting

  • Conditions:   Refractory Acute Lymphoblastic Leukemia;   Relapsed Acute Lymphoblastic Leukemia
    Interventions:   Drug: Pevonedistat;   Drug: Vincristine;   Drug: Dexamethasone;   Drug: PEG-asparaginase;   Drug: Doxorubicin;   Drug: Cytarabine;   Drug: Methotrexate;   Drug: Hydrocortisone
    Sponsors:   Julio Barredo;   Takeda
    Recruiting

  • Condition:   Septic Shock
    Interventions:   Drug: Hydrocortisone, sodium succinate;   Drug: Normal saline
    Sponsors:   Jerry Zimmerman;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Canadian Institutes of Health Research (CIHR);   Canadian Critical Care Trials Group;   Children's Hospital of Eastern Ontario
    Recruiting

  • Conditions:   Heroin Dependence;   Opioid Use Disorder
    Interventions:   Drug: Buprenorphine-Naloxone;   Drug: Morphine;   Drug: Yohimbine;   Drug: Hydrocortisone;   Drug: Matching Placebo for Yohimbine;   Drug: Matching Placebo for Hydrocortisone
    Sponsor:   Wayne State University
    Recruiting

  • Condition:   Congenital Adrenal Hyperplasia
    Interventions:   Drug: Abiraterone acetate;   Drug: Placebo;   Drug: Hydrocortisone;   Drug: Fludrocortisone
    Sponsors:   University of Texas Southwestern Medical Center;   National Institutes of Health Clinical Center (CC);   University of Michigan;   Children's Hospital Los Angeles;   Feinstein Institute for Medical Research
    Not yet recruiting

  • Conditions:   Sepsis;   Septic Shock;   Metabolic Disturbance
    Interventions:   Drug: vitamin C, vitamin B1, hydrocortisone;   Drug: Normal saline
    Sponsors:   Beth Israel Deaconess Medical Center;   Open Philanthropy Project
    Recruiting

  • Conditions:   Eczema, Infantile;   Eczema;   Atopic Dermatitis Eczema;   Atopic Dermatitis
    Interventions:   Combination Product: Tri-lipid skin barrier cream (Epiceram);   Combination Product: Fluticasone propionate Cream 0.05%
    Sponsors:   Stanford University;   King's College London;   National Jewish Health
    Not yet recruiting

  • Condition:   Prostate Cancer
    Interventions:   Drug: 177Lu-J591;   Drug: Ketoconazole;   Drug: Hydrocortisone;   Drug: 111In-J591
    Sponsor:   Weill Medical College of Cornell University
    Recruiting

  • Conditions:   Hormone-Resistant Prostate Cancer;   Recurrent Prostate Carcinoma;   Stage I Prostate Cancer;   Stage II Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer
    Interventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
    Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Atopic Dermatitis
    Interventions:   Drug: Crisaborole ointment, 2%;   Drug: Hydrocortisone butyrate cream, 0.1%;   Drug: Pimecrolimus cream, 1%;   Drug: Crisaborole Vehicle
    Sponsor:   Pfizer
    Recruiting

  • Condition:   Arthroplasty, Replacement, Knee
    Intervention:   Other: Music Therapy
    Sponsor:   University of Alabama at Birmingham
    Recruiting

  • Condition:   Sepsis
    Interventions:   Drug: Vitamin C;   Drug: Thiamine;   Drug: Hydrocortisone;   Drug: Vitamin C Placebo;   Drug: Thiamine Placebo;   Drug: Hydrocortisone Placebo
    Sponsors:   Emory University;   The Marcus Foundation
    Recruiting

  • Conditions:   Adult Burkitt Lymphoma;   B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma;   Diffuse Large B-Cell Lymphoma;   MYC Gene Mutation;   Plasmablastic Lymphoma
    Interventions:   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Drug: Ixazomib Citrate;   Other: Laboratory Biomarker Analysis;   Drug: Methotrexate;   Drug: Prednisone;   Biological: Rituximab;   Drug: Therapeutic Hydrocortisone;   Drug: Vincristine Sulfate
    Sponsors:   Northwestern University;   National Cancer Institute (NCI);   Millennium Pharmaceuticals, Inc.
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Mifepristone;   Drug: Placebo - Cap
    Sponsors:   Johns Hopkins University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Abdominal Aortic Aneurysm
    Interventions:   Biological: MSC's;   Drug: Placebo
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Stress, Psychological;   Stress, Emotional;   Stress, Physiological
    Interventions:   Behavioral: Ethnic and Racial Identity Promotion;   Behavioral: Academic Skills Promotion
    Sponsors:   Northwestern University;   Harvard University
    Recruiting

  • Condition:   HAI
    Interventions:   Behavioral: Pet dog;   Behavioral: Unfamiliar dog;   Behavioral: Nonsocial control
    Sponsors:   University of Arizona;   University of Virginia
    Recruiting

  • Conditions:   Stress Reaction;   Behavior, Social
    Interventions:   Behavioral: Therapy Dog;   Behavioral: Stuffed Toy Dog
    Sponsors:   University of Chicago;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Not yet recruiting

  • Conditions:   Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome;   Blasts 0.1 Percent or More of Bone Marrow Nucleated Cells;   Blasts 5 Percent or More of Bone Marrow Nucleated Cells;   Recurrent Acute Myeloid Leukemia;   Recurrent High Risk Myelodysplastic Syndrome;   Refractory Acute Myeloid Leukemia
    Interventions:   Drug: Azacitidine;   Drug: Cytarabine;   Drug: Fludarabine Phosphate;   Drug: Methotrexate;   Drug: Pevonedistat;   Drug: Therapeutic Hydrocortisone
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Anxiety Disorder;   Depression;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
    Interventions:   Drug: minocycline hydrochloride;   Other: placebo;   Other: laboratory biomarker analysis;   Other: Questionnaire administration
    Sponsor:   Ohio State University Comprehensive Cancer Center
    Recruiting

  • Condition:   Acute Myeloid Leukemia
    Interventions:   Drug: Venetoclax;   Drug: Cytarabine;   Drug: Idarubicin;   Drug: Intrathecal Triple Therapy
    Sponsors:   St. Jude Children's Research Hospital;   Gateway for Cancer Research
    Recruiting

  • Conditions:   Lymphoblastic Leukemia, Acute, Childhood;   Lymphoblastic Lymphoma;   Peripheral T-cell Lymphoma
    Interventions:   Drug: Temsirolimus;   Drug: Etoposide;   Drug: Cyclophosphamide;   Drug: Methotrexate;   Drug: Hydrocortisone;   Drug: Cytarabine
    Sponsors:   Therapeutic Advances in Childhood Leukemia Consortium;   Pfizer
    Recruiting

  • Condition:   Congenital Adrenal Hyperplasia
    Intervention:   Drug: Abiraterone acetate
    Sponsors:   University of Texas Southwestern Medical Center;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   University of Michigan;   Children's Hospital Los Angeles
    Recruiting

  • Conditions:   Acute Lymphoblastic Leukemia, in Relapse;   Acute Lymphoblastic Leukemia With Failed Remission
    Interventions:   Drug: Palbociclib Oral Capsule;   Drug: Intrathecal Triple Therapy Given IT;   Drug: Dexamethasone;   Drug: Bortezomib;   Drug: Dasatinib;   Drug: Doxorubicin
    Sponsors:   St. Jude Children's Research Hospital;   Pfizer
    Recruiting

  • Conditions:   Hypertension;   Mild Cognitive Impairment
    Interventions:   Behavioral: Mindfulness and DASH Diet Education;   Behavioral: Education group
    Sponsor:   Ohio State University
    Recruiting

  • Conditions:   B Acute Lymphoblastic Leukemia;   BCR-ABL1 Fusion Protein Expression;   Minimal Residual Disease;   Philadelphia Chromosome Positive;   T Acute Lymphoblastic Leukemia;   Untreated Adult Acute Lymphoblastic Leukemia;   Untreated Childhood Acute Lymphoblastic Leukemia
    Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Dexrazoxane Hydrochloride;   Drug: Doxorubicin;   Drug: Etoposide;   Biological: Filgrastim;   Drug: Ifosfamide;   Drug: Imatinib Mesylate;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Methylprednisolone;   Drug: Pegaspargase;   Drug: Prednisolone;   Other: Questionnaire Administration;   Drug: Therapeutic Hydrocortisone;   Drug: Thioguanine;   Drug: Vincristine Sulfate
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI);   University of Milano Bicocca
    Recruiting

  • Conditions:   Acute Leukemia of Ambiguous Lineage;   B Acute Lymphoblastic Leukemia;   KMT2A Gene Rearrangement;   Mixed Phenotype Acute Leukemia
    Interventions:   Drug: Azacitidine;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Hydrocortisone Sodium Succinate;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Pegaspargase;   Other: Pharmacological Study;   Drug: Prednisolone;   Drug: Thioguanine;   Drug: Vincristine Sulfate
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Stress, Physiological
    Interventions:   Behavioral: Virtual Reality with Meditation;   Behavioral: Audio Control;   Behavioral: Virtual reality Control
    Sponsor:   Ohio State University
    Recruiting

  • Condition:   B Acute Lymphoblastic Leukemia
    Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Asparaginase;   Biological: Blinatumomab;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Mitoxantrone Hydrochloride;   Drug: Pegaspargase;   Other: Pharmacological Study;   Drug: Therapeutic Hydrocortisone;   Drug: Thioguanine;   Drug: Vincristine Sulfate
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Psychological Stress
    Interventions:   Behavioral: Stress immediately before learning in males;   Behavioral: Sham control immediately before learning in males;   Behavioral: Stress 30 minutes before learning in males;   Behavioral: Sham control 30 minutes before learning in males;   Behavioral: Stress immediately before learning in females;   Behavioral: Sham control immediately before learning in females;   Behavioral: Stress 30 minutes before learning in females;   Behavioral: Sham control 30 minutes before learning in females
    Sponsors:   Ohio Northern University;   National Institute of Mental Health (NIMH)
    Recruiting

  • Conditions:   Normal Physiology;   Healthy
    Interventions:   Behavioral: NEA;   Behavioral: DEA
    Sponsor:   National Institute of Environmental Health Sciences (NIEHS)
    Recruiting

  • Conditions:   Stroke;   Stroke, Acute;   Brain Injury, Acute
    Interventions:   Biological: Umbilical Cord Blood;   Other: Placebo
    Sponsors:   Joanne Kurtzberg, MD;   The Marcus Foundation;   Emory University;   M.D. Anderson Cancer Center
    Recruiting

  • Condition:   Leukemia
    Interventions:   Biological: anti-thymocyte globulin;   Drug: asparaginase;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: melphalan;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: mitoxantrone hydrochloride;   Drug: pegaspargase;   Drug: prednisolone;   Drug: prednisone;   Drug: therapeutic hydrocortisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Procedure: allogeneic bone marrow transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: umbilical cord blood transplantation
    Sponsors:   Dutch Childhood Oncology Group;   BFM Germany;   CORS Monza Italy;   Associazione Italiana Ematologia Oncologia Pediatrica;   Australian and New Zealand Children's Oncology Group;   BFM Austria;   CLCG France Belgium Portugal;   COALL Germany;   CPH, Czech republic;   DFCI consortium USA;   FRALLE France;   Hong Kong;   MD Anderson USA;   NOPHO Scandinavian countries;   PINDA, Chile;   PPLLSG Poland;   Seattle USA;   SJCRH USA;   UKCCSG United Kingdom
    Recruiting

  • Conditions:   Leukemia, Lymphocytic;   Lymphoblastic Lymphoma;   T-cell Lymphoma;   T-cell Leukemia;   Recurrent Disease;   Acute Leukemia
    Interventions:   Drug: Palbociclib;   Drug: Cytarabine;   Drug: Methotrexate;   Drug: Hydrocortisone;   Drug: Doxorubicin;   Drug: Prednisolone;   Drug: Vincristine;   Drug: Pegaspargase
    Sponsor:   Children's Oncology Group
    Recruiting

  • Condition:   Acute Lymphoblastic Leukemia, Pediatric
    Interventions:   Drug: Pegaspargase;   Drug: Erwinia asparaginase;   Drug: Cyclophosphamide;   Drug: CYTARABINE;   Drug: DASATINIB;   Drug: DEXAMETHASONE;   Drug: Dexrazoxane;   Drug: Doxorubicin;   Drug: ETOPOSIDE;   Drug: HYDROCORTISONE;   Drug: LEUCOVORIN CALCIUM;   Drug: MERCAPTOPURINE;   Drug: METHOTREXATE;   Drug: NELARABINE;   Drug: Vincristine
    Sponsors:   Dana-Farber Cancer Institute;   Servier
    Recruiting

  • Condition:   Acute Lymphoblastic Leukemia (ALL)
    Interventions:   Drug: Carfilzomib;   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: PEG-asparaginase;   Drug: Vincristine;   Drug: Intrathecal (IT) Methotrexate;   Drug: Intrathecal Triple Therapy (Intrathecal Cytarabine, Hydrocortisone, and Methotrexate);   Drug: 6-Mercaptopurine;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin
    Sponsors:   Amgen;   Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) - Study Design & Execution Collaborator;   Innovative Therapies For Children with Cancer Consortium
    Recruiting

  • Conditions:   B Acute Lymphoblastic Leukemia;   B Lymphoblastic Lymphoma;   Blasts More Than 25 Percent of Bone Marrow Nucleated Cells;   Down Syndrome
    Interventions:   Drug: Asparaginase Erwinia chrysanthemi;   Biological: Blinatumomab;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Doxorubicin;   Drug: Doxorubicin Hydrochloride;   Drug: Leucovorin;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Mercaptopurine Oral Suspension;   Drug: Methotrexate;   Drug: Prednisolone;   Drug: Prednisone;   Drug: Thioguanine;   Drug: Vincristine;   Drug: Vincristine Sulfate
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Acute Myeloid Leukemia (AML);   Acute Lymphoblastic Leukemia (ALL);   Neuroblastoma;   Solid Tumors
    Interventions:   Drug: Idasanutlin;   Drug: Venetoclax;   Drug: Cyclophosphamide;   Drug: Topotecan;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Intrathecal Chemotherapy
    Sponsor:   Hoffmann-La Roche
    Not yet recruiting

  • Condition:   Acute Lymphoblastic Leukemia
    Interventions:   Drug: ITMHA;   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: Pegaspargase;   Drug: Asparaginase Erwinia Chrysanthemi;   Drug: Bortezomib;   Drug: Vorinostat;   Drug: Cyclophosphamide;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Leucovorin Calcium;   Drug: Cytarabine;   Drug: Etoposide;   Drug: Vincristine
    Sponsors:   St. Jude Children's Research Hospital;   Gateway for Cancer Research;   Texas Children's Hospital
    Recruiting

  • Condition:   Cushing Syndrome
    Interventions:   Drug: Relacorilant;   Other: Placebo
    Sponsor:   Corcept Therapeutics
    Recruiting

  • Conditions:   Acute Myeloid Leukemia;   Myelodysplastic Syndromes
    Interventions:   Drug: Azacitidine;   Drug: Decitabine;   Drug: Cytarabine;   Drug: Daunorubicin;   Drug: Etoposide;   Combination Product: ITMHA;   Drug: Idarubicin;   Drug: Fludarabine;   Drug: Mitoxantrone;   Drug: Erwinia asparaginase;   Drug: Sorafenib;   Drug: G-CSF;   Drug: Dexrazoxane;   Biological: Stem Cell Transplant
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting